Latest On UroGen Pharma Ltd (URGN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-12 01:46 EST | News | Urogen Pharma Ltd (URGN) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-11 11:35 EST | News | UroGen Pharma GAAP EPS of -$1.30 beats by $0.01, revenue of $17.19M beats by $0.1M | N/A | |
| 2023-05-01 14:45 EST | News | UroGen Pharma jumps amid takeover speculation | N/A | |
| 2023-03-17 00:28 EST | News | UroGen Pharma Ltd. (URGN) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-16 08:54 EST | News | UroGen Pharma GAAP EPS of -$1.22 misses by $0.14, revenue of $18.09M misses by $0.42M | N/A | |
| 2023-02-08 13:43 EST | News | UroGen: Struggling With Revenue And With Cash Runway | N/A | |
| 2023-02-08 13:42 EST | News | UroGen Pharma falls after Jefferies lower rating to hold | N/A | |
| 2022-11-21 16:23 EST | News | UroGen Pharma: Jelmyto Sales Growing Steadily, Concerns Remain | N/A | |
| 2022-11-11 00:31 EST | News | UroGen Pharma GAAP EPS of -$1.13 beats by $0.05, revenue of $16.1M misses by $4.05M | N/A | |
| 2022-11-11 00:31 EST | News | UroGen Pharma Ltd. (URGN) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-09-29 01:36 EST | News | UroGen gets FDA nod for extending duration of Jelmyto admixture | N/A | |
| 2022-08-11 16:57 EST | News | UroGen Pharma GAAP EPS of -$1.18 beats by $0.12, revenue of $16.6M misses by $0.68M, reaffirms FY revenue guidance | N/A | |
| 2022-08-11 16:57 EST | News | Urogen Pharma Ltd (URGN) CEO Elizabeth Barrett on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-11 11:36 EST | News | UroGen Pharma Ltd. (URGN) CEO Liz Barrett on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 15:51 EST | News | UroGen Pharma GAAP EPS of -$1.25 beats by $0.09, revenue of $13.56M misses by $1.62M | N/A | |
| 2022-04-27 12:58 EST | News | UroGen wins Buy rating at Berenberg on potential in bladder cancer | N/A | |
| 2022-03-29 13:44 EST | News | UroGen Pharma gets FDA nod to begin phase 1 trial of UGN-301 for bladder cancer | N/A | |
| 2022-03-22 05:43 EST | News | UroGen Pharma GAAP EPS of -$1.27 misses by $0.07, revenue of $16.17M misses by $0.32M | N/A | |
| 2022-03-22 05:42 EST | News | UroGen Pharma Ltd.'s (URGN) CEO Liz Barrett on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-03 18:51 EST | News | UroGen begins phase 3 trial of UGN-102 to treat bladder cancer | N/A | |
| 2021-12-03 22:14 EST | News | UroGen pharma reports inducement grant to 13 new employees | N/A | |
| 2021-11-19 21:27 EST | News | Urogen Pharma (URGN) Investor Presentation - Slideshow | N/A | |
| 2021-11-15 14:17 EST | News | UroGen Pharma EPS misses by $0.06, misses on revenue | N/A | |
| 2021-11-15 14:17 EST | News | UroGen Pharma slips on Q3 earnings miss and disappointing guidance | N/A | |
| 2021-11-15 14:16 EST | News | UroGen Pharma Ltd. (URGN) CEO Liz Barrett on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-05 17:37 EST | News | UroGen bladder cancer candidate shows meaningful, durable response in mid-stage trial | N/A | |
| 2021-08-07 08:17 EST | News | UroGen Pharma Ltd. (URGN) CEO Liz Barrett on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-04 17:03 EST | News | UroGen Pharma EPS in-line, beats on revenue | N/A | |
| 2021-07-29 06:21 EST | News | UroGen Pharma inks license and supply agreement with Neopharm | N/A | |
| 2021-07-22 05:19 EST | News | UroGen Pharma sees Q2 net revenue of $13M, above consensus | N/A | |
| 2021-07-22 05:12 EST | News | UroGen Pharma (URGN) Presents At HealthVirtual Conference - Slideshow | N/A | |
| 2021-03-19 04:02 EST | News | UroGen Pharma EPS misses by $0.01, beats on revenue | N/A | |
| 2021-03-19 04:02 EST | News | UroGen Pharma to receive $75M non-dilutive funding from RTW Investments | N/A | |
| 2021-03-19 04:00 EST | News | UroGen Pharma Ltd.'s (URGN) CEO Liz Barrett on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-18 07:00 EST | News | Urogen Pharma (URGN) Presents At Oppenheimer 31st Annual Healthcare Conference - Slideshow | N/A | |
| 2021-03-02 02:15 EST | News | Jelmyto And UGN-102 Will Likely Drive Strong Returns For UroGen Shareholders | N/A | |
| 2021-01-21 00:41 EST | News | Urogen Pharma (URGN) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow | N/A | |
| 2021-01-13 19:56 EST | News | UroGen Pharma teams up with MD Anderson to advance treatment for bladder cancer | N/A | |
| 2021-01-11 09:16 EST | News | UroGen Is Worth $50/Share, Should It Trade At Revenue Multiples Consistent With Its Peers | N/A | |
| 2021-01-10 19:55 EST | News | URGN Is Worth $50/Share Should It Trade At Revenue Multiples Consistent With Its Peers | N/A | |
| 2021-01-05 12:58 EST | Analyst Rating | The Analyst Target Price has decreased from $43 to $41. | Neutral | |
| 2020-11-26 21:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 13:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 05:19 EST | Analyst Rating | The Analyst Target Price has decreased from $44.14 to $43. | Neutral | |
| 2020-11-10 13:24 EST | Earnings Estimate | An EPS average of -$1.33 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-09 21:42 EST | News | UroGen Pharma EPS beats by $0.15, beats on revenue | N/A | |
| 2020-11-09 21:40 EST | News | UroGen Pharma's (URGN) CEO Liz Barrett on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-08 01:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 10:13 EST | Insider Trade | Mark Schoenberg has directly disposed of 101 shares and currently holds 19,343 shares. | Sell | |
About UroGen Pharma Ltd (URGN):
UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing solutions for specialty cancers and urologic diseases. The company's lead product candidates are UGN-101 and UGN-102, which are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-201, a proprietary immunotherapy product candidate for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. It also has a strategic research agreement with the Johns Hopkins University to study the checkpoint inhibitors combined with RTGel in glioblastoma multiforme to treat brain cancer. UroGen Pharma Ltd. was founded in 2004 and is based in Princeton, New Jersey.
General
- Name UroGen Pharma Ltd
- Symbol URGN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 187
- Fiscal Year EndDecember
- IPO Date2017-05-04
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.urogen.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 110.91
- Price/Book (Most Recent Quarter) 3.63
- Enterprise Value Revenue 83.61
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$1.44
- Operating Margin -3463%
- Return on Assets -45%
- Return on Equity -83%
- Revenue 3.83 million
- Earnings Per Share -$4.89
- Revenue Per Share $0.18
- Gross Profit 18000
- Quarterly Earnings Growth 1966.7%
View More
Highlights
- Market Capitalization 423.52 million
- EBITDA -81143000
- Analyst Target Price $41
- Book Value Per Share $5.46
View More
Share Statistics
- Shares Outstanding 22.09 million
- Shares Float 18.76 million
- % Held by Insiders 1274%
- % Held by Institutions 75.18%
- Shares Short 2.76 million
- Shares Short Prior Month 2.72 million
- Short Ratio 15.65
- Short % of Float 16%
- Short % of Shares Outstanding 13%
View More
Technicals
- Beta 1.23
- 52 Week High $30.89
- 52 Week Low $13.12
- 50 Day Moving Average 22.09
- 200 Day Moving Average 21.19
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
UroGen Pharma Ltd (URGN) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
UroGen Pharma Ltd (URGN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-09 | $N/A | -$1.31 | -$1.47 | 11.1% |
| 2020-06-30 | 2020-08-10 | $N/A | -$1.44 | -$1.52 | 5.16% |
| 2020-03-31 | 2020-05-07 | $N/A | -$1.79 | -$1.58 | -13.16% |
| 2019-12-31 | 2020-03-02 | $N/A | -$1.86 | -$1.70 | -9.57% |
| 2019-09-30 | 2019-11-12 | $N/A | -$1.06 | -$1.28 | 17.42% |
| 2019-06-30 | 2019-08-09 | $18000 | -$1.08 | -$1.20 | 9.93% |
| 2019-03-31 | 2019-05-09 | $N/A | -$1.11 | -$1.27 | 12.25% |
| 2018-12-31 | 2019-02-28 | $845000 | -$1.46 | -$1.28 | -14.51% |
| 2018-09-30 | 2018-11-12 | $283000 | -$1.28 | -$1.11 | -15.32% |
| 2018-06-30 | 2018-08-14 | $364000 | -$1.14 | -$0.93 | -22.58% |
| 2018-03-31 | 2018-05-15 | $481000 | -$0.88 | -$0.63 | -39.68% |
| 2017-12-31 | 2018-03-15 | $327000 | -$0.74 | -$0.64 | -16.22% |
| 2017-09-30 | 2017-11-14 | $7.81 million | -$0.02 | $0.11 | -118.18% |
| 2017-06-30 | 2017-08-14 | $-38000 | -$0.68 | -$1.77 | 61.58% |
UroGen Pharma Ltd (URGN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
UroGen Pharma Ltd (URGN) Chart:
UroGen Pharma Ltd (URGN) News:
Below you will find a list of latest news for UroGen Pharma Ltd (URGN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
UroGen Pharma Ltd (URGN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 646.46 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 524.1 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 314.66 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 8.62 | CALL | 0 | 5 | 251.29 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 2.5 | CALL | 0 | 46 | 110.23 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 1.24 | CALL | 6 | 287 | 111.25 | FALSE | 1.24 | 0 |
| 2024-05-17 | 17.5 | 0.5 | CALL | 5 | 173 | 105.95 | FALSE | -0.09 | -0.15 |
| 2024-05-17 | 20 | 0.12 | CALL | 0 | 42 | 130.56 | FALSE | 0 | 0 |
| 2024-05-17 | 22.5 | 1.25 | CALL | 0 | 20 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 25 | 0.15 | CALL | 0 | 197 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 30 | 0.05 | CALL | 0 | 18 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 35 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.19 | PUT | 0 | 12 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0.59 | PUT | 0 | 10 | 106.47 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0.6 | PUT | 0 | 432 | 103.53 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 2.05 | PUT | 0 | 120 | 96.01 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 2.33 | PUT | 0 | 36 | 106.47 | TRUE | 0 | 0 |
| 2024-05-17 | 20 | 7.1 | PUT | 0 | 20 | 106.91 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 0 | PUT | 0 | 0 | 180.74 | TRUE | 0 | 0 |
| 2024-05-17 | 25 | 0 | PUT | 0 | 0 | 234.6 | TRUE | 0 | 0 |
| 2024-05-17 | 30 | 0 | PUT | 0 | 0 | 276.43 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 19.75 | PUT | 0 | 0 | 309.72 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 357.38 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 330.12 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 229.41 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | CALL | 0 | 0 | 130.03 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 2.6 | CALL | 0 | 16 | 121.17 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 0 | CALL | 0 | 0 | 110.7 | FALSE | 0 | 0 |
| 2024-06-21 | 17.5 | 0.95 | CALL | 0 | 2 | 98.59 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 0.85 | CALL | 0 | 1 | 99.73 | FALSE | 0 | 0 |
| 2024-06-21 | 22.5 | 0.65 | CALL | 0 | 1 | 102.47 | FALSE | 0 | 0 |
| 2024-06-21 | 25 | 0 | CALL | 0 | 0 | 115.19 | FALSE | 0 | 0 |
| 2024-06-21 | 30 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0 | PUT | 0 | 0 | 124.16 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 1.5 | PUT | 0 | 200 | 99.88 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 0 | PUT | 0 | 0 | 101.75 | TRUE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | PUT | 0 | 0 | 96.72 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 0 | PUT | 0 | 0 | 136.25 | TRUE | 0 | 0 |
| 2024-06-21 | 22.5 | 0 | PUT | 0 | 0 | 100.11 | TRUE | 0 | 0 |
| 2024-06-21 | 25 | 0 | PUT | 0 | 0 | 158.48 | TRUE | 0 | 0 |
| 2024-06-21 | 30 | 0 | PUT | 0 | 0 | 171.4 | TRUE | 0 | 0 |
| 2024-07-19 | 2.5 | 0 | CALL | 0 | 0 | 325.62 | TRUE | 0 | 0 |
| 2024-07-19 | 5 | 0 | CALL | 0 | 0 | 274.41 | TRUE | 0 | 0 |
| 2024-07-19 | 7.5 | 0 | CALL | 0 | 0 | 171.7 | TRUE | 0 | 0 |
| 2024-07-19 | 10 | 0 | CALL | 0 | 0 | 124.67 | TRUE | 0 | 0 |
| 2024-07-19 | 12.5 | 0 | CALL | 0 | 0 | 89.63 | TRUE | 0 | 0 |
| 2024-07-19 | 15 | 0 | CALL | 0 | 0 | 104.57 | FALSE | 0 | 0 |
| 2024-07-19 | 17.5 | 2.17 | CALL | 0 | 690 | 100.73 | FALSE | 0 | 0 |
| 2024-07-19 | 20 | 0 | CALL | 0 | 0 | 110.02 | FALSE | 0 | 0 |
| 2024-07-19 | 22.5 | 0 | CALL | 0 | 0 | 134.25 | FALSE | 0 | 0 |
| 2024-07-19 | 25 | 0 | CALL | 0 | 0 | 119.49 | FALSE | 0 | 0 |
| 2024-07-19 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 7.5 | 0 | PUT | 0 | 0 | 146.45 | FALSE | 0 | 0 |
| 2024-07-19 | 10 | 0 | PUT | 0 | 0 | 138.6 | FALSE | 0 | 0 |
| 2024-07-19 | 12.5 | 0 | PUT | 0 | 0 | 133.16 | FALSE | 0 | 0 |
| 2024-07-19 | 15 | 2.71 | PUT | 0 | 680 | 90.93 | TRUE | 0 | 0 |
| 2024-07-19 | 17.5 | 0 | PUT | 0 | 0 | 107.16 | TRUE | 0 | 0 |
| 2024-07-19 | 20 | 0 | PUT | 0 | 0 | 119.29 | TRUE | 0 | 0 |
| 2024-07-19 | 22.5 | 0 | PUT | 0 | 0 | 130.59 | TRUE | 0 | 0 |
| 2024-07-19 | 25 | 0 | PUT | 0 | 0 | 103.37 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | CALL | 0 | 0 | 271.39 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 13.07 | CALL | 0 | 1 | 227.68 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 157.4 | TRUE | 0 | 0 |
| 2024-08-16 | 10 | 5.45 | CALL | 0 | 21 | 102.09 | TRUE | 0 | 0 |
| 2024-08-16 | 12.5 | 0 | CALL | 0 | 0 | 85.95 | TRUE | 0 | 0 |
| 2024-08-16 | 15 | 2.2 | CALL | 0 | 364 | 94.83 | FALSE | 0 | 0 |
| 2024-08-16 | 17.5 | 1 | CALL | 0 | 43 | 132.1 | FALSE | 0 | 0 |
| 2024-08-16 | 20 | 2 | CALL | 0 | 24 | 94.92 | FALSE | 0 | 0 |
| 2024-08-16 | 22.5 | 2.85 | CALL | 0 | 4 | 108.24 | FALSE | 0 | 0 |
| 2024-08-16 | 25 | 1.5 | CALL | 0 | 27 | 97.12 | FALSE | 0 | 0 |
| 2024-08-16 | 30 | 0.4 | CALL | 0 | 147 | 112.75 | FALSE | 0 | 0 |
| 2024-08-16 | 35 | 1.15 | CALL | 0 | 15 | 110.95 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 112.53 | FALSE | 0 | 0 |
| 2024-08-16 | 10 | 1.05 | PUT | 0 | 20 | 134.76 | FALSE | 0 | 0 |
| 2024-08-16 | 12.5 | 2.5 | PUT | 0 | 5 | 85.22 | FALSE | 0 | 0 |
| 2024-08-16 | 15 | 3.25 | PUT | 0 | 5 | 90.25 | TRUE | 0 | 0 |
| 2024-08-16 | 17.5 | 4.78 | PUT | 0 | 3 | 102.16 | TRUE | 0 | 0 |
| 2024-08-16 | 20 | 7.4 | PUT | 0 | 5 | 91.39 | TRUE | 0 | 0 |
| 2024-08-16 | 22.5 | 7.4 | PUT | 0 | 35 | 102.56 | TRUE | 0 | 0 |
| 2024-08-16 | 25 | 9.32 | PUT | 0 | 1 | 131.27 | TRUE | 0 | 0 |
| 2024-08-16 | 30 | 0 | PUT | 0 | 0 | 129.31 | TRUE | 0 | 0 |
| 2024-08-16 | 35 | 19.25 | PUT | 0 | 0 | 145.48 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | CALL | 0 | 0 | 241.78 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 0 | CALL | 0 | 0 | 177.32 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | CALL | 0 | 0 | 128.57 | TRUE | 0 | 0 |
| 2024-11-15 | 10 | 0 | CALL | 0 | 0 | 122.32 | TRUE | 0 | 0 |
| 2024-11-15 | 12.5 | 0 | CALL | 0 | 0 | 101.12 | TRUE | 0 | 0 |
| 2024-11-15 | 15 | 0 | CALL | 0 | 0 | 101.98 | FALSE | 0 | 0 |
| 2024-11-15 | 17.5 | 2.65 | CALL | 0 | 25 | 87.98 | FALSE | 0 | 0 |
| 2024-11-15 | 20 | 0 | CALL | 0 | 0 | 88.82 | FALSE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | CALL | 0 | 0 | 93.8 | FALSE | 0 | 0 |
| 2024-11-15 | 25 | 0 | CALL | 0 | 0 | 88.27 | FALSE | 0 | 0 |
| 2024-11-15 | 30 | 0 | CALL | 0 | 0 | 80.4 | FALSE | 0 | 0 |
| 2024-11-15 | 35 | 1.1 | CALL | 0 | 1 | 89.84 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | PUT | 0 | 0 | 104.13 | FALSE | 0 | 0 |
| 2024-11-15 | 10 | 0 | PUT | 0 | 0 | 106.37 | FALSE | 0 | 0 |
| 2024-11-15 | 12.5 | 1.95 | PUT | 0 | 0 | 77.58 | FALSE | 0 | 0 |
| 2024-11-15 | 15 | 0 | PUT | 0 | 0 | 99.5 | TRUE | 0 | 0 |
| 2024-11-15 | 17.5 | 0 | PUT | 0 | 0 | 83.71 | TRUE | 0 | 0 |
| 2024-11-15 | 20 | 0 | PUT | 0 | 0 | 103.32 | TRUE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | PUT | 0 | 0 | 80.48 | TRUE | 0 | 0 |
| 2024-11-15 | 25 | 0 | PUT | 0 | 0 | 98.37 | TRUE | 0 | 0 |
| 2024-11-15 | 30 | 0 | PUT | 0 | 0 | 92.27 | TRUE | 0 | 0 |
| 2024-11-15 | 35 | 18.95 | PUT | 0 | 0 | 97.03 | TRUE | 0 | 0 |
Latest URGN Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 5 | $6.56 |
| Jun 13, 2022 7:59 PM EST | 16 | $6.56 |
| Jun 13, 2022 7:59 PM EST | 42 | $6.58 |
| Jun 13, 2022 7:59 PM EST | 100 | $6.57 |
| Jun 13, 2022 7:59 PM EST | 100 | $6.57 |
UroGen Pharma Ltd (URGN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120035684/0001209191-20-035684-index.htm |
| 2018-10-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1668243/000000000018033311/0000000000-18-033311-index.htm |
| 2019-05-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1668243/000000000019008192/0000000000-19-008192-index.htm |
| 2019-05-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1668243/000000000019008687/0000000000-19-008687-index.htm |
| 2019-05-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1668243/000000000019009150/0000000000-19-009150-index.htm |
| 2019-12-27 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1668243/000000000019016806/0000000000-19-016806-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000031506619001377/0000315066-19-001377-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000083423720007990/0000834237-20-007990-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000090221919000060/0000902219-19-000060-index.htm |
| 2020-01-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000090221920000110/0000902219-20-000110-index.htm |
| 2018-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000095012318008882/0000950123-18-008882-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000108514619000751/0001085146-19-000751-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000108514620000852/0001085146-20-000852-index.htm |
| 2019-01-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000114420419001440/0001144204-19-001440-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000117891319000488/0001178913-19-000488-index.htm |
| 2019-06-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1668243/000117891319001642/0001178913-19-001642-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000117891320000371/0001178913-20-000371-index.htm |
| 2020-02-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1668243/000117891320000395/0001178913-20-000395-index.htm |
| 2018-07-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000119312518217088/0001193125-18-217088-index.htm |
| 2018-08-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000119312518242444/0001193125-18-242444-index.htm |
| 2018-08-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000119312518263657/0001193125-18-263657-index.htm |
| 2018-09-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000119312518275855/0001193125-18-275855-index.htm |
| 2018-09-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000119312518279401/0001193125-18-279401-index.htm |
| 2018-10-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000119312518287790/0001193125-18-287790-index.htm |
| 2018-10-12 | F-3 | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1668243/000119312518298482/0001193125-18-298482-index.htm |
| 2018-10-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1668243/000119312518298488/0001193125-18-298488-index.htm |
| 2018-10-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1668243/000119312518306177/0001193125-18-306177-index.htm |
| 2018-10-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000119312518313813/0001193125-18-313813-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519001714/0001193125-19-001714-index.htm |
| 2019-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519005114/0001193125-19-005114-index.htm |
| 2019-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519014088/0001193125-19-014088-index.htm |
| 2019-01-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1668243/000119312519014093/0001193125-19-014093-index.htm |
| 2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519016388/0001193125-19-016388-index.htm |
| 2019-01-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1668243/000119312519016433/0001193125-19-016433-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519055714/0001193125-19-055714-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1668243/000119312519122589/0001193125-19-122589-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519142301/0001193125-19-142301-index.htm |
| 2019-05-14 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1668243/000119312519146553/0001193125-19-146553-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519158432/0001193125-19-158432-index.htm |
| 2019-05-29 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1668243/000119312519159661/0001193125-19-159661-index.htm |
| 2019-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519168284/0001193125-19-168284-index.htm |
| 2019-06-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1668243/000119312519168298/0001193125-19-168298-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519217507/0001193125-19-217507-index.htm |
| 2019-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519253710/0001193125-19-253710-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519288338/0001193125-19-288338-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519289211/0001193125-19-289211-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519289316/0001193125-19-289316-index.htm |
| 2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519298551/0001193125-19-298551-index.htm |
| 2019-12-20 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1668243/000119312519320929/0001193125-19-320929-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312519320975/0001193125-19-320975-index.htm |
| 2019-12-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1668243/000119312519325909/0001193125-19-325909-index.htm |
| 2020-01-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1668243/000119312520000672/0001193125-20-000672-index.htm |
| 2020-03-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312520081537/0001193125-20-081537-index.htm |
| 2020-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312520108412/0001193125-20-108412-index.htm |
| 2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312520143480/0001193125-20-143480-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312520165697/0001193125-20-165697-index.htm |
| 2020-08-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1668243/000119312520215023/0001193125-20-215023-index.htm |
| 2020-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312520232097/0001193125-20-232097-index.htm |
| 2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000119312520241611/0001193125-20-241611-index.htm |
| 2019-01-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003113/0001209191-19-003113-index.htm |
| 2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003174/0001209191-19-003174-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003281/0001209191-19-003281-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003282/0001209191-19-003282-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003283/0001209191-19-003283-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003284/0001209191-19-003284-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003285/0001209191-19-003285-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003286/0001209191-19-003286-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003287/0001209191-19-003287-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003288/0001209191-19-003288-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003289/0001209191-19-003289-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003291/0001209191-19-003291-index.htm |
| 2019-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003292/0001209191-19-003292-index.htm |
| 2019-01-15 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003804/0001209191-19-003804-index.htm |
| 2019-01-15 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119003805/0001209191-19-003805-index.htm |
| 2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119005801/0001209191-19-005801-index.htm |
| 2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119005803/0001209191-19-005803-index.htm |
| 2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119005805/0001209191-19-005805-index.htm |
| 2019-03-07 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119017931/0001209191-19-017931-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119017932/0001209191-19-017932-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119017933/0001209191-19-017933-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119021091/0001209191-19-021091-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119021092/0001209191-19-021092-index.htm |
| 2019-03-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119021635/0001209191-19-021635-index.htm |
| 2019-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119030594/0001209191-19-030594-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119034777/0001209191-19-034777-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119034780/0001209191-19-034780-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119034785/0001209191-19-034785-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119034787/0001209191-19-034787-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119034788/0001209191-19-034788-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119034790/0001209191-19-034790-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119034793/0001209191-19-034793-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119035245/0001209191-19-035245-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119046282/0001209191-19-046282-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119047107/0001209191-19-047107-index.htm |
| 2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119048672/0001209191-19-048672-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119056923/0001209191-19-056923-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057044/0001209191-19-057044-index.htm |
| 2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057692/0001209191-19-057692-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057753/0001209191-19-057753-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057755/0001209191-19-057755-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057766/0001209191-19-057766-index.htm |
| 2019-12-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919119059250/0001209191-19-059250-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120002366/0001209191-20-002366-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005200/0001209191-20-005200-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005211/0001209191-20-005211-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005215/0001209191-20-005215-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120006208/0001209191-20-006208-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120006210/0001209191-20-006210-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120006211/0001209191-20-006211-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120006212/0001209191-20-006212-index.htm |
| 2020-02-13 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120009118/0001209191-20-009118-index.htm |
| 2020-02-13 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120009122/0001209191-20-009122-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120009943/0001209191-20-009943-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120012017/0001209191-20-012017-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120016275/0001209191-20-016275-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025893/0001209191-20-025893-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025903/0001209191-20-025903-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025904/0001209191-20-025904-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120029079/0001209191-20-029079-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120030900/0001209191-20-030900-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120034672/0001209191-20-034672-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120035676/0001209191-20-035676-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120035677/0001209191-20-035677-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120035678/0001209191-20-035678-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120035679/0001209191-20-035679-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120035680/0001209191-20-035680-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120035682/0001209191-20-035682-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120035684/0001209191-20-035684-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120043873/0001209191-20-043873-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120043874/0001209191-20-043874-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120048883/0001209191-20-048883-index.htm |
| 2020-09-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120049741/0001209191-20-049741-index.htm |
| 2020-09-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120049936/0001209191-20-049936-index.htm |
| 2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120049937/0001209191-20-049937-index.htm |
| 2020-10-05 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120053632/0001209191-20-053632-index.htm |
| 2020-10-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120053637/0001209191-20-053637-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120053641/0001209191-20-053641-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120055037/0001209191-20-055037-index.htm |
| 2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1668243/000120919120056066/0001209191-20-056066-index.htm |
| 2019-10-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000138713119007448/0001387131-19-007448-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1668243/000138713120001809/0001387131-20-001809-index.htm |
| 2018-11-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1668243/000156459018029081/0001564590-18-029081-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1668243/000156459019005323/0001564590-19-005323-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1668243/000156459019017568/0001564590-19-017568-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1668243/000156459019031042/0001564590-19-031042-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1668243/000156459019042553/0001564590-19-042553-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1668243/000156459020007970/0001564590-20-007970-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1668243/000156459020019410/0001564590-20-019410-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1668243/000156459020019415/0001564590-20-019415-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1668243/000156459020022352/0001564590-20-022352-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1668243/000156459020038598/0001564590-20-038598-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1668243/000156459020038611/0001564590-20-038611-index.htm |
| 2018-10-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1668243/999999999518002728/9999999995-18-002728-index.htm |
| 2020-01-02 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1668243/999999999520000010/9999999995-20-000010-index.htm |
UroGen Pharma Ltd (URGN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of UroGen Pharma Ltd (URGN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1274%Institutional Ownership: 7518%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-04-27 | Stephen Mullennix | Chief Operating Officer | Sell | 145.00 | 24.35 | 3,530.75 | 10,084.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025893/0001209191-20-025893-index.htm |
| 2020-04-26 | Stephen Mullennix | Chief Operating Officer | Buy | 417.00 | 10,229.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025893/0001209191-20-025893-index.htm | ||
| 2020-10-15 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 1,017.00 | 21.72 | 22,089.24 | 10,405.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120055037/0001209191-20-055037-index.htm |
| 2020-02-14 | Stephen Mullennix | Chief Operating Officer | Buy | 1,759.00 | 10,424.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120009943/0001209191-20-009943-index.htm | ||
| 2020-10-15 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 407.00 | 21.82 | 8,882.49 | 11,422.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120055037/0001209191-20-055037-index.htm |
| 2020-10-15 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 976.00 | 21.80 | 21,276.02 | 11,829.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120055037/0001209191-20-055037-index.htm |
| 2020-01-03 | Elizabeth A. Barrett | Chief Executive Officer | Buy | 105,688.00 | 122,236.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120002366/0001209191-20-002366-index.htm | ||
| 2020-10-15 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 4,917.00 | 12,805.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120055037/0001209191-20-055037-index.htm | ||
| 2019-02-06 | Fred E Cohen | Director | Buy | 15,000.00 | 16.99 | 254,850.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119021091/0001209191-19-021091-index.htm |
| 2019-11-15 | Elizabeth A. Barrett | Chief Executive Officer | Buy | 1,548.00 | 26.00 | 40,248.00 | 1,548.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057044/0001209191-19-057044-index.htm |
| 2020-05-12 | Elizabeth A. Barrett | Chief Executive Officer | Buy | 35,229.00 | 157,465.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120029079/0001209191-20-029079-index.htm | ||
| 2019-11-21 | Elizabeth A. Barrett | Chief Executive Officer | Buy | 7,530.00 | 28.00 | 210,840.00 | 16,548.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057766/0001209191-19-057766-index.htm |
| 2020-04-27 | Mark Schoenberg | Chief Medical Officer | Sell | 70.00 | 24.35 | 1,704.50 | 17,711.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025904/0001209191-20-025904-index.htm |
| 2020-04-26 | Mark Schoenberg | Chief Medical Officer | Buy | 208.00 | 17,781.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025904/0001209191-20-025904-index.htm | ||
| 2020-03-04 | Mark Schoenberg | Chief Medical Officer | Buy | 1,042.00 | 17,918.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120016275/0001209191-20-016275-index.htm | ||
| 2020-06-04 | Mark Schoenberg | Chief Medical Officer | Sell | 349.00 | 27.51 | 9,601.97 | 18,404.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120034672/0001209191-20-034672-index.htm |
| 2020-07-27 | Mark Schoenberg | Chief Medical Officer | Sell | 70.00 | 23.51 | 1,645.70 | 18,543.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120043873/0001209191-20-043873-index.htm |
| 2020-07-26 | Mark Schoenberg | Chief Medical Officer | Buy | 209.00 | 18,613.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120043873/0001209191-20-043873-index.htm | ||
| 2020-06-04 | Mark Schoenberg | Chief Medical Officer | Buy | 1,042.00 | 18,753.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120034672/0001209191-20-034672-index.htm | ||
| 2020-09-04 | Mark Schoenberg | Chief Medical Officer | Sell | 348.00 | 20.20 | 7,029.60 | 19,236.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120049741/0001209191-20-049741-index.htm |
| 2020-10-26 | Mark Schoenberg | Chief Medical Officer | Sell | 101.00 | 20.95 | 2,115.56 | 19,343.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120056066/0001209191-20-056066-index.htm |
| 2020-10-26 | Mark Schoenberg | Chief Medical Officer | Buy | 208.00 | 19,444.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120056066/0001209191-20-056066-index.htm | ||
| 2020-09-04 | Mark Schoenberg | Chief Medical Officer | Buy | 1,041.00 | 19,584.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120049741/0001209191-20-049741-index.htm | ||
| 2019-03-27 | Arie Belldegrun | Director | Buy | 128,000.00 | 4.02 | 514,560.00 | 212,211.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119021635/0001209191-19-021635-index.htm |
| 2019-08-20 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 1,416.00 | 33.07 | 46,827.12 | 2,751.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119047107/0001209191-19-047107-index.htm |
| 2019-11-20 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 354.00 | 28.41 | 10,057.14 | 3,439.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057753/0001209191-19-057753-index.htm |
| 2019-11-20 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 1,042.00 | 3,793.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057753/0001209191-19-057753-index.htm | ||
| 2019-08-20 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 4,167.00 | 4,167.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119047107/0001209191-19-047107-index.htm | ||
| 2019-02-14 | Stephen Mullennix | Chief Operating Officer | Sell | 2,804.00 | 37.30 | 104,589.20 | 4,230.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119017932/0001209191-19-017932-index.htm |
| 2019-03-06 | Mark Schoenberg | Chief Medical Officer | Sell | 1,991.00 | 37.30 | 74,264.30 | 4,338.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119017933/0001209191-19-017933-index.htm |
| 2020-01-27 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 667.00 | 29.28 | 19,529.76 | 4,438.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005215/0001209191-20-005215-index.htm |
| 2019-03-21 | Mark Schoenberg | Chief Medical Officer | Buy | 272.00 | 37.01 | 10,066.45 | 4,610.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119021092/0001209191-19-021092-index.htm |
| 2020-01-26 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 1,666.00 | 5,105.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005215/0001209191-20-005215-index.htm | ||
| 2019-05-14 | Stephen Mullennix | Chief Operating Officer | Sell | 608.00 | 37.98 | 23,091.84 | 5,381.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119030594/0001209191-19-030594-index.htm |
| 2019-06-04 | Mark Schoenberg | Chief Medical Officer | Buy | 1,042.00 | 5,652.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119035245/0001209191-19-035245-index.htm | ||
| 2019-05-14 | Stephen Mullennix | Chief Operating Officer | Buy | 1,759.00 | 5,989.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119030594/0001209191-19-030594-index.htm | ||
| 2019-09-04 | Mark Schoenberg | Chief Medical Officer | Sell | 343.00 | 33.92 | 11,634.56 | 6,007.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119048672/0001209191-19-048672-index.htm |
| 2020-02-20 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 360.00 | 29.68 | 10,684.80 | 6,120.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120012017/0001209191-20-012017-index.htm |
| 2019-03-04 | Mark Schoenberg | Chief Medical Officer | Buy | 1,042.00 | 6,329.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119017933/0001209191-19-017933-index.htm | ||
| 2019-09-04 | Mark Schoenberg | Chief Medical Officer | Buy | 1,041.00 | 6,350.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119048672/0001209191-19-048672-index.htm | ||
| 2020-04-27 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 141.00 | 24.35 | 3,433.35 | 6,396.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025903/0001209191-20-025903-index.htm |
| 2020-02-20 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 1,042.00 | 6,480.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120012017/0001209191-20-012017-index.htm | ||
| 2019-08-15 | Stephen Mullennix | Chief Operating Officer | Sell | 608.00 | 31.65 | 19,243.20 | 6,532.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119046282/0001209191-19-046282-index.htm |
| 2020-04-26 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 417.00 | 6,537.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120025903/0001209191-20-025903-index.htm | ||
| 2019-02-14 | Stephen Mullennix | Chief Operating Officer | Buy | 7,034.00 | 7,034.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119017932/0001209191-19-017932-index.htm | ||
| 2020-05-20 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 358.00 | 25.07 | 8,975.06 | 7,079.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120030900/0001209191-20-030900-index.htm |
| 2019-08-14 | Stephen Mullennix | Chief Operating Officer | Buy | 1,759.00 | 7,140.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119046282/0001209191-19-046282-index.htm | ||
| 2020-07-27 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 141.00 | 23.51 | 3,314.91 | 7,355.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120043874/0001209191-20-043874-index.htm |
| 2020-05-20 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 1,041.00 | 7,437.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120030900/0001209191-20-030900-index.htm | ||
| 2020-07-26 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 417.00 | 7,496.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120043874/0001209191-20-043874-index.htm | ||
| 2019-11-14 | Stephen Mullennix | Chief Operating Officer | Sell | 608.00 | 26.00 | 15,806.36 | 7,683.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119056923/0001209191-19-056923-index.htm |
| 2020-09-01 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Sell | 509.00 | 22.82 | 11,615.38 | 7,888.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120048883/0001209191-20-048883-index.htm |
| 2019-11-19 | Mark Schoenberg | Chief Medical Officer | Buy | 1,960.00 | 28.17 | 55,213.20 | 7,967.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057692/0001209191-19-057692-index.htm |
| 2019-11-14 | Stephen Mullennix | Chief Operating Officer | Buy | 1,759.00 | 8,291.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119056923/0001209191-19-056923-index.htm | ||
| 2020-09-01 | PETER P. PFREUNDSCHUH | Chief Financial Officer | Buy | 1,042.00 | 8,397.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120048883/0001209191-20-048883-index.htm | ||
| 2020-01-27 | Stephen Mullennix | Chief Operating Officer | Sell | 684.00 | 29.26 | 20,013.84 | 8,665.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005211/0001209191-20-005211-index.htm |
| 2019-12-04 | Mark Schoenberg | Chief Medical Officer | Buy | 1,042.00 | 9,009.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119059250/0001209191-19-059250-index.htm | ||
| 2019-11-20 | Elizabeth A. Barrett | Chief Executive Officer | Buy | 7,470.00 | 28.00 | 209,160.00 | 9,018.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919119057755/0001209191-19-057755-index.htm |
| 2020-01-27 | Mark Schoenberg | Chief Medical Officer | Sell | 322.00 | 29.15 | 9,386.30 | 9,177.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005200/0001209191-20-005200-index.htm |
| 2020-01-26 | Stephen Mullennix | Chief Operating Officer | Buy | 1,666.00 | 9,349.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005211/0001209191-20-005211-index.htm | ||
| 2020-01-26 | Mark Schoenberg | Chief Medical Officer | Buy | 833.00 | 9,499.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120005200/0001209191-20-005200-index.htm | ||
| 2020-02-14 | Stephen Mullennix | Chief Operating Officer | Sell | 612.00 | 28.04 | 17,160.48 | 9,812.00 | https://www.sec.gov/Archives/edgar/data/1668243/000120919120009943/0001209191-20-009943-index.htm |